Tatva Chintan

  • Market Cap: Small Cap
  • Industry: Specialty Chemicals
  • ISIN: INE0GK401011
  • NSEID: TATVA
  • BSEID: 543321
INR
1,775.60
29.9 (1.71%)
BSENSE

Sep 23, 03:28 PM

BSE+NSE Vol: 1.02 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1003512,
    "name": "Tatva Chintan",
    "stock_name": "Tatva Chintan",
    "full_name": "Tatva Chintan Pharma Chem Ltd",
    "name_url": "stocks-analysis/tatva-chintan",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,775.60",
    "chg": 29.9,
    "chgp": "1.71%",
    "dir": 1,
    "prev_price": "1,745.70",
    "mcapval": "4,184.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543321,
    "symbol": "TATVA",
    "ind_name": "Specialty Chemicals",
    "ind_code": 11,
    "sector_id": 74,
    "indexname": "India SENSEX",
    "isin": "INE0GK401011",
    "curr_date": "Sep 23, 03:28 PM",
    "curr_time": "15:30 PM",
    "last_traded_at": "Sep 23, 03:28 PM IST",
    "bse_nse_vol": "1.02 lacs",
    "exc_status": "Active",
    "traded_date": "Sep 23, 2026",
    "traded_date_str": "2026 09 23",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/tatva-chintan-1003512-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Tatva Chintan Pharma Chem Ltd Gains 10.20%: 5 Key Factors Driving the Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tatva-chintan-pharma-chem-ltd-gains-1020-5-key-factors-driving-the-weeks-momentum-4198115",
        "imagepath": "",
        "date": "2026-09-19 12:00:05",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>15 Sep:</strong> Stock declines 3.73% amid technical momentum shift</p>\n                    <p><strong>16 Sep:</strong> Intraday high reached with 7.32% surge</p>\n                    <p><strong>17 Sep:</strong> Mojo Grade upgraded to Buy following strong financials</p>\n                    <p><strong>18 Sep:</strong> Continued gains close week at Rs.1,769.40 (+3.83%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,605.65</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.1,769.40</di..."
      },
      {
        "title": "Tatva Chintan Pharma Chem Ltd Upgraded to Buy on Strong Financial and Technical Momentum",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/tatva-chintan-pharma-chem-ltd-upgraded-to-buy-on-strong-financial-and-technical-momentum-4195822",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/TatvaChintanPha_mojoScore_4195822.png",
        "date": "2026-09-17 08:34:26",
        "description": "Tatva Chintan Pharma Chem Ltd has seen its investment rating upgraded from Hold to Buy, reflecting a marked improvement across technical indicators, financial trends, valuation metrics, and overall quality. This upgrade, effective from 16 September 2026, is underpinned by robust quarterly results, bullish technical signals, and a compelling growth trajectory that outpaces broader market benchmarks."
      },
      {
        "title": "Tatva Chintan Pharma Chem Ltd Sees Bullish Momentum Shift Amid Technical Upgrades",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tatva-chintan-pharma-chem-ltd-sees-bullish-momentum-shift-amid-technical-upgrades-4195669",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/TatvaChintanPha_technicaldot_4195669.png",
        "date": "2026-09-17 08:04:49",
        "description": "Tatva Chintan Pharma Chem Ltd, a specialty chemicals company, has witnessed a significant shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underscored by strong signals from key technical indicators such as MACD, Bollinger Bands, and moving averages, alongside an upgraded MarketsMOJO rating from Hold to Buy, reflecting growing investor optimism."
      },
      {
        "title": "Tatva Chintan Pharma Chem Ltd Surges 7.32% to Day's High of Rs 1646.5 — Outperforms Sector by 6.42 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tatva-chintan-pharma-chem-ltd-hits-intraday-high-with-732-surge-on-16-sep-2026-4195422",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/TatvaChintanPha_priceRelatedfactors_4195422.png",
        "date": "2026-09-16 15:31:35",
        "description": "The Sensex advanced 0.4% on 16 Jun 2026, yet Tatva Chintan Pharma Chem Ltd outpaced the market with a 7.32% gain, reaching an intraday high of Rs 1646.5. This 6.42 percentage-point outperformance over the Specialty Chemicals sector signals a distinctly stock-specific rally rather than a broad market lift."
      },
      {
        "title": "Tatva Chintan Pharma Chem Ltd Sees Technical Momentum Shift Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tatva-chintan-pharma-chem-ltd-sees-technical-momentum-shift-amid-mixed-market-signals-4192806",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/TatvaChintanPha_technicaldot_4192806.png",
        "date": "2026-09-15 08:04:02",
        "description": "Tatva Chintan Pharma Chem Ltd, a small-cap player in the specialty chemicals sector, has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a recent downgrade in its Mojo Grade from Buy to Hold, the stock’s technical indicators present a nuanced picture, reflecting both strength and caution as it navigates volatile market conditions."
      },
      {
        "title": "Tatva Chintan Pharma Chem Ltd Downgraded to Hold Amid Mixed Technical and Valuation Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/tatva-chintan-pharma-chem-ltd-downgraded-to-hold-amid-mixed-technical-and-valuation-signals-4192305",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/TatvaChintanPha_mojoScore_4192305.png",
        "date": "2026-09-14 08:16:16",
        "description": "Tatva Chintan Pharma Chem Ltd, a specialty chemicals company, has seen its investment rating downgraded from Buy to Hold as of 11 September 2026. This adjustment reflects a nuanced assessment across four key parameters: quality, valuation, financial trend, and technicals. While the company continues to demonstrate strong quarterly financial performance and market-beating returns, evolving technical indicators and valuation concerns have tempered the overall outlook."
      },
      {
        "title": "Tatva Chintan Pharma Chem Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/tatva-chintan-pharma-chem-ltd-is-rated-buy-4190374",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/TatvaChintanPha_mojoScore_4190374.png",
        "date": "2026-09-11 10:10:44",
        "description": "Tatva Chintan Pharma Chem Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 28 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 September 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Tatva Chintan Pharma Chem Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/tatva-chintan-pharma-chem-ltd-is-rated-buy-4175985",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/TatvaChintanPha_mojoScore_4175985.png",
        "date": "2026-08-31 10:10:39",
        "description": "Tatva Chintan Pharma Chem Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 28 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 August 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Tatva Chintan Pharma Chem Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/tatva-chintan-pharma-chem-ltd-is-rated-buy-4162440",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/TatvaChintanPha_mojoScore_4162440.png",
        "date": "2026-08-20 10:10:40",
        "description": "Tatva Chintan Pharma Chem Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 28 July 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 20 August 2026, providing investors with the latest insights into the company’s performance and outlook."
      }
    ],
    "total": 529,
    "sid": "1003512",
    "stock_news_url": "https://www.marketsmojo.com/news/tatva-chintan-pharma-chem-1003512"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "17-Sep-2026",
      "details": "Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
      "datetime": "08-Sep-2026",
      "details": "Intimation of Credit Rating",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "08-Sep-2026",
      "details": "Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Tatva Chintan Pharma Chem Ltd has declared <strong>20%</strong> dividend, ex-date: 11 Sep 26",
          "dt": "2026-09-11",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Tatva Chintan Pharma Chem Ltd Gains 10.20%: 5 Key Factors Driving the Week’s Momentum

2026-09-19 12:00:05

Key Events This Week

15 Sep: Stock declines 3.73% amid technical momentum shift

16 Sep: Intraday high reached with 7.32% surge

17 Sep: Mojo Grade upgraded to Buy following strong financials

18 Sep: Continued gains close week at Rs.1,769.40 (+3.83%)

stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

17-Sep-2026 | Source : BSE

Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.

Announcement under Regulation 30 (LODR)-Credit Rating

08-Sep-2026 | Source : BSE

Intimation of Credit Rating

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

08-Sep-2026 | Source : BSE

Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Tatva Chintan Pharma Chem Ltd has declared 20% dividend, ex-date: 11 Sep 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available